'Tomato' patent case at the EPO results in second referral to the Enlarged Board

The European Patent Office (EPO) has referred a case relating to dried tomatoes to the Enlarged Board of Appeal for a second time.

In his latest IPKat post, EIP's Darren Smyth discusses the most recent developments.

UK Patents Court Finds Sustained-Release Quetiapine Patent Invalid, by Darren Smyth

Partner Darren Smyth has had an article on the Seroquel case published on the website of the Controlled Release Society. The regular ‘Inside Track’ feature provides insider knowledge on recent developments in the science and technology of controlled r...

23andMe's first patent causes a rift with customers

A recent IPKat post by Darren Smyth highlights the adverse consumer reaction to the issuance of a patent to a US company 23andMe which offers to sequence your genome and tell you about its implications for your ancestry and health.

Referrals to the Enlarged Board of Appeal over procedural matters: a good use of EBA resources?

In a recent IPKat post, Darren Smyth ponders whether the Boards of Appeal of the European Patent Office should be referring cases to the Enlarged Board of Appeal on matters of procedural requirements, and whether this is an appropriate allocation of EB...

EIP welcomes three new members to the partnership

Three EIP senior associates, Matthew Blaseby, Neil Forsyth, and Chris Price, have become partners in EIP Partnership LLP. All three started their careers in intellectual property at EIP and passed their qualification exams for UK and European Patent A...

'Tomato' patent case at the EPO results in second referral to the Enlarged Board

Our cookies

Essential

Analytics

Social media & third party